TRIM58 inhibitors refer to a class of chemical compounds that target and inhibit the activity of the TRIM58 protein, a member of the TRIM (Tripartite Motif) family of proteins. TRIM proteins are characterized by the presence of a RING (Really Interesting New Gene) finger domain, B-box domains, and a coiled-coil region. These structural motifs play critical roles in mediating protein-protein interactions and the ubiquitination process. The ubiquitination system is essential for regulating protein turnover in the cell, marking proteins for degradation via the proteasome. TRIM58 itself has been identified as an E3 ubiquitin ligase, meaning that it facilitates the attachment of ubiquitin molecules to specific target proteins, leading to their degradation. By inhibiting TRIM58, chemical compounds in this class modulate the ubiquitin-proteasome pathway, which is involved in various cellular processes such as protein homeostasis, signaling pathways, and the regulation of transcription factors.
The inhibition of TRIM58 has sparked significant interest due to its potential impact on the regulation of intracellular protein degradation. TRIM58 inhibitors are often investigated to understand how blocking this particular protein might alter ubiquitination patterns, which could impact numerous cellular events. Furthermore, since TRIM58 is involved in critical cellular pathways, researchers are keen to explore how inhibiting its activity could influence processes such as cell differentiation, development, and stress responses. Inhibitors targeting TRIM proteins like TRIM58 are valuable tools for probing the functions of these ubiquitin ligases and for studying their roles in maintaining cellular equilibrium. The chemical characterization of these inhibitors often involves a detailed examination of their binding affinities, specificity, and the structural changes they induce upon interacting with TRIM58, which is crucial for understanding their molecular mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that prevents the degradation of ubiquitinated proteins. Since TRIM58 is involved in ubiquitination, MG-132 can affect its functional outcomes. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
Inhibitor of NEDD8-activating enzyme (NAE). By inhibiting the neddylation process, it can indirectly influence ubiquitination processes that TRIM58 may be part of. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Irreversible ubiquitin-activating enzyme (E1) inhibitor. Can affect the upstream processes of ubiquitination, potentially influencing TRIM58's function. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Specific proteasome inhibitor that can lead to accumulation of ubiquitinated proteins, indirectly impacting TRIM58-mediated ubiquitination. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor. It interferes with the breakdown of ubiquitinated proteins, which can potentially affect TRIM58's function. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates the activity of E3 ubiquitin ligase. By influencing E3 ligases, it can alter ubiquitination processes and potentially TRIM58's function. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
Modulates the activity of E3 ubiquitin ligase, potentially influencing ubiquitination processes associated with TRIM58. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
MDM2 antagonist which can lead to an increase in p53 levels. As p53 can influence ubiquitination pathways, this may indirectly influence TRIM58's activity. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $110.00 $268.00 $1533.00 $5103.00 | 9 | |
p53/MDM2 interaction inhibitor. By modulating p53 activity, ubiquitination processes related to TRIM58 might be influenced. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
PI3K inhibitor known to block autophagy. Autophagy and ubiquitination are interconnected processes, so TRIM58's function might be indirectly influenced. | ||||||